Lumexa Imaging (NASDAQ:LMRI) Raised to "Strong-Buy" at KeyCorp

Key Points

• KeyCorp upgraded Lumexa Imaging to “strong buy,” while analysts’ overall average rating remains “Buy” with an average price target of $17.50. Ratings are mixed, including a sell rating from Weiss Ratings and a hold rating from Wall Street Zen.
• Lumexa reported quarterly EPS of $0.20, beating the $0.03 consensus estimate, on revenue of $264.16 million. Management issued fiscal 2026 EPS guidance of $0.710 to $0.770.
• LMRI opened at $9.88, below its 50-day moving average of $11.39 and 200-day average of $10.42, while several institutional investors—including Jupiter Topco, BlackRock and Brigade Capital—recently established positions.

Lumexa Imaging (NASDAQ:LMRI - Get Free Report) was upgraded by stock analysts at KeyCorp to a "strong-buy" rating in a research note issued to investors on Thursday, Zacks reports.

Several other equities analysts have also commented on LMRI. Deutsche Bank Aktiengesellschaft set a $16.00 target price on Lumexa Imaging in a report on Thursday, August 13th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Lumexa Imaging in a research note on Tuesday. Wall Street Zen downgraded shares of Lumexa Imaging from a "buy" rating to a "hold" rating in a research report on Saturday, September 12th. Finally, Barclays raised their target price on shares of Lumexa Imaging from $9.00 to $13.00 and gave the stock an "overweight" rating in a report on Friday, August 28th. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Lumexa Imaging has an average rating of "Buy" and an average price target of $17.50.

Lumexa Imaging Price Performance

LMRI opened at $9.88 on Thursday. The company has a debt-to-equity ratio of 1.40, a quick ratio of 1.44 and a current ratio of 1.44. Lumexa Imaging has a 1 year low of $6.45 and a 1 year high of $19.45. The stock has a market capitalization of $949.17 million and a PE ratio of -20.16. The company's 50 day simple moving average is $11.39 and its 200 day simple moving average is $10.42.

Lumexa Imaging (NASDAQ:LMRI - Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.17. The company had revenue of $264.16 million for the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. As a group, sell-side analysts expect that Lumexa Imaging will post 0.25 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Jupiter Topco LLC acquired a new position in shares of Lumexa Imaging during the 2nd quarter worth $24,269,000. Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in shares of Lumexa Imaging during the fourth quarter worth approximately $27,750,000. BlackRock Inc. acquired a new position in shares of Lumexa Imaging during the 2nd quarter valued at about $15,771,000. Brigade Capital Management LP acquired a new position in Lumexa Imaging during the 2nd quarter worth approximately $7,511,000. Finally, Monashee Investment Management LLC bought a new stake in Lumexa Imaging during the fourth quarter worth $2,775,000.

Lumexa Imaging Company Profile

Lumexa Imaging, Inc NASDAQ: LMRI is an outpatient diagnostic imaging company that provides medical imaging services to patients and referring healthcare providers in the United States. Its services are designed to support the diagnosis, monitoring and management of a wide range of medical conditions.

The company's imaging capabilities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), ultrasound, mammography and X-ray services. Lumexa also provides related radiology and imaging-support services through its outpatient centers and other care-delivery arrangements.

Lumexa Imaging was formerly known as Akumin Inc and adopted the Lumexa Imaging name as part of its corporate rebranding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.